The Centers for Disease Control estimates that 1.6
to 3.8 million concussions occur each year, which is an all-time high
for the United States. It is also reported
that the majority of fatal sports-related brain injuries occur in
children 18 years old and younger, and that 47% of athletes do not
report feeling a concussion’s symptoms. Therefore,
substantial new technology is being developed in an attempt to prevent
concussions in younger athletes. Additionally, pharmaceutical
treatments are being developed to mediate post-concussion symptoms.
These new technologies experience a direct relationship with the
increasing number of concussions reported per year. Now, companies can
utilize research and development tax credits to support these
innovative efforts.